Vargas-Mendoza, N.; Morales-González, Á.; Morales-Martínez, M.; Soriano-Ursúa, M.A.; Delgado-Olivares, L.; Sandoval-Gallegos, E.M.; Madrigal-Bujaidar, E.; Álvarez-González, I.; Madrigal-Santillán, E.; Morales-Gonzalez, J.A.
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications. Biomedicines 2020, 8, 122.
https://doi.org/10.3390/biomedicines8050122
AMA Style
Vargas-Mendoza N, Morales-González Á, Morales-Martínez M, Soriano-Ursúa MA, Delgado-Olivares L, Sandoval-Gallegos EM, Madrigal-Bujaidar E, Álvarez-González I, Madrigal-Santillán E, Morales-Gonzalez JA.
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications. Biomedicines. 2020; 8(5):122.
https://doi.org/10.3390/biomedicines8050122
Chicago/Turabian Style
Vargas-Mendoza, Nancy, Ángel Morales-González, Mauricio Morales-Martínez, Marvin A. Soriano-Ursúa, Luis Delgado-Olivares, Eli Mireya Sandoval-Gallegos, Eduardo Madrigal-Bujaidar, Isela Álvarez-González, Eduardo Madrigal-Santillán, and José A. Morales-Gonzalez.
2020. "Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications" Biomedicines 8, no. 5: 122.
https://doi.org/10.3390/biomedicines8050122
APA Style
Vargas-Mendoza, N., Morales-González, Á., Morales-Martínez, M., Soriano-Ursúa, M. A., Delgado-Olivares, L., Sandoval-Gallegos, E. M., Madrigal-Bujaidar, E., Álvarez-González, I., Madrigal-Santillán, E., & Morales-Gonzalez, J. A.
(2020). Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications. Biomedicines, 8(5), 122.
https://doi.org/10.3390/biomedicines8050122
